Correct obviously to be drawn down at each of the stages of development.
Funding for the trials, that will be restarted for the chosen drug and cancer. Phases 1 to 3. How many years to commercialisation?
Where's the revenue coming from to fund SPL in meantime? Annual tax refund will be severely impacted with little on going research. Low customer sales. How many quarters cash left?
I guess May webinar as an update will be state of affairs.
Correct obviously to be drawn down at each of the stages of...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.005(4.17%) |
Mkt cap ! $49.44M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 11.5¢ | $9.147K | 76.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 532267 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 12500 | 1 |
View Market Depth
| Last trade - 15.42pm 06/05/2024 (20 minute delay) ? |
| SPL (ASX) Chart |